<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04453215</url>
  </required_header>
  <id_info>
    <org_study_id>1298</org_study_id>
    <nct_id>NCT04453215</nct_id>
  </id_info>
  <brief_title>Laser Therapy for Patients With Systemic Lupus Erythematosus</brief_title>
  <official_title>The Effect of Dental Laser Therapy for Patients With Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Merve Benli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease that has detrimental&#xD;
      effects on connective tissue and other organs. The musculoskeletal system is one of the most&#xD;
      affected systems in this group of patients including the temporomandibular joint. The most&#xD;
      common symptoms when muscle involvement in SLE are muscle atrophy decreased muscle strength&#xD;
      and myopathy. SLE activity and long-term corticosteroid use are thought to be responsible for&#xD;
      these symptoms, thus, SLE patients are accepted to be at higher risk for temporomandibular&#xD;
      joint disorders (TMD). Low-level laser therapy(LLLT) is frequently used in the treatment of&#xD;
      TMD due to its pain relief and anti-inflammatory effect. Thus, in this study, LLLT has been&#xD;
      used to evaluate this treatment modality on the chewing function and pain values of SLE&#xD;
      patients with myogenic TMD.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 12, 2019</start_date>
  <completion_date type="Actual">March 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 23, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain value</measure>
    <time_frame>2 months</time_frame>
    <description>Pain intensity was evaluated by using Visual Analog Scale(VAS).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>chewing function</measure>
    <time_frame>2 months</time_frame>
    <description>The chewing function was evaluated by measuring the geometric mean diameter of crushed test food.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Muscle Pain</condition>
  <condition>Chewing Function</condition>
  <arm_group>
    <arm_group_label>test group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SLE patients treated with infrared laser irradiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>SLE patients treated with red laser irradiation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no therapy group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GaAlAs semiconductor diode laser device</intervention_name>
    <description>low-level laser therapy</description>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_label>test group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having myogenic temporomandibular joint disorder,&#xD;
&#xD;
          -  Following a stable medical regime,&#xD;
&#xD;
          -  Showing minimum pain intensity of 50 mm on the visual analog scale.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having concurrent systemic diseases,&#xD;
&#xD;
          -  Using antimalarial drugs,&#xD;
&#xD;
          -  Wearing removable prosthesis,&#xD;
&#xD;
          -  History of facial trauma.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>merve benli, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul university,Faculty of Dentistry</name>
      <address>
        <city>Fatih</city>
        <zip>34452</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 28, 2020</study_first_submitted>
  <study_first_submitted_qc>June 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2020</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Dr. Merve Benli</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myalgia</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>When requested by a researcher, the data can be shared without the identity of the patient.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>The data will become available when confirmed, and it will be available for one year.</ipd_time_frame>
    <ipd_access_criteria>The study protocol and patient selection will be shared.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

